Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

AJVS. 2021; 70(1): 126-134


Pathological Evaluation of Nigella Sativa Oil and Resveratrol Against Fipronil Induced Toxicity In Male Albino Rats

Mona A. Mohamed, El-Sayed E. Mehanna, Samah S. Oda, Hossam G. Tohamy, Asmaa F. Khafaga.




Abstract

Fipronil (FPN) is a broad-spectrum insecticide widely used in agriculture and veterinary applications. FPN repressed the cellular enzymatic and non-enzymatic antioxidants, resulted in oxidative injuries. Both nigella sativa oil (NSO) and resveratrol (RSV) had antioxidant activities. The present study aimed to assess the ameliorative effect of NSO and RSV against FPN induced toxicosis in male albino rats. Rats were divided into six groups. The first group was administered FPN (10 mg/kg); the second received FPN (10 mg/kg) and NSO (1ml/kg); the third group received FPN (10mg/kg) and RSV (20mg/kg); fourth, and fifth were treated with NSO (1ml/kg) and RSV (20mg/kg), respectively. The sixth group was the control. The results showed that FPN significantly increased serum levels of urea, creatinine, alanine aminotransferase, aspartate aminotransferase and alkaline phosphatase. FPN-intoxicated rats revealed a significant increase in the level of MDA and significant decrease in GSH level in liver and brain tissues. While, kidney tissue revealed a significant decrease in renal GSH concentration and non-significant increase in renal MDA. Furthermore, FPN showed histological changes in liver, kidney, brain and heart tissues. In contrast, administration of NSO and RSV ameliorated the FPN-induced oxidative damage, and histopathological alterations possibly due to their antioxidant properties.

Key words: Fipronil, nigella sativa, resveratrol, histopathology






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.